Analyze Diet
Veterinary ophthalmology2002; 5(4); 263-267; doi: 10.1046/j.1463-5224.2002.00234.x

Survival of equine herpesvirus-4, feline herpesvirus-1, and feline calicivirus in multidose ophthalmic solutions.

Abstract: To determine survival over time of infectious equine herpesvirus-4, feline herpesvirus-1, and feline calicivirus in three commercially available and commonly used ophthalmic solutions (eyewash, fluorescein, and proparacaine HCl). Methods: Viruses used in this study were originally isolated from eyes of animals referred to the University of Illinois. Equine herpesvirus-4 was propagated in MDBK cells and feline herpesvirus-1 and feline calicivirus in CRFK cells. Methods: After separately inoculating a designated solution with a specific titer of an individual virus, solutions were incubated per manufacturer's recommendations, either at 4 degrees C or 25 degrees C. Virus titers within solutions were subsequently measured at 1, 8, and 24 h and 3, 5 and 7 days post inoculation using either plaque or TCID50 assays. Results: Equine herpesvirus-4, feline herpesvirus-1, and feline calicivirus were present in eyewash for 7 days, 5 days, and 7 days, respectively. Eyewash did not decrease survival time of any virus when compared to controls. Equine herpesvirus-4 and feline herpesvirus-1, both enveloped viruses, were not recovered at any time > or = 1 h post inoculation in fluorescein. Feline calicivirus, a nonenveloped virus, was present in fluorescein for 7 days. Equine herpesvirus-4 and feline herpesvirus-1 did not remain infectious in proparacaine at any time > or = 1 h post inoculation, but feline calicivirus was recovered at up to 24 h post inoculation. Conclusions: Equine herpesvirus-4, feline herpesvirus-1, and feline calicivirus may be readily transmissible via the eyewash solution used in this study. Risk of iatrogenic transmission of the three viruses used in this study was significantly reduced in both fluorescein and proparacaine solutions. Feline calicivirus, the only nonenveloped virus evaluated, remained viable longer in both fluorescein and proparacaine solutions.
Publication Date: 2002-11-26 PubMed ID: 12445296DOI: 10.1046/j.1463-5224.2002.00234.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research examines how long equine herpesvirus-4, feline herpesvirus-1, and feline calicivirus live in three different ophthalmic solutions commonly used for eye irritations in animals.

Research Methodology

  • The researchers used three specific viruses that were originally isolated from the eyes of animals referred to the University of Illinois. These viruses were equine herpesvirus-4, feline herpesvirus-1, and feline calicivirus. The equine herpesvirus was grown in MDBK cells, while the feline viruses were propagated in CRFK cells.
  • The study method involved inoculating each ophthalmic solution with a specific titer of each virus. These solutions were then stored according to the manufacturer’s instructions at either 4 degrees Celsius or 25 degrees Celsius.
  • The virus titers within the solutions were measured at several intervals – 1, 8, and 24 hours, and then 3, 5 and 7 days after inoculation. The measurement was done using either plaque or TCID50 assays.

Research Findings

  • The three viruses under study remained present in eyewash for different durations. The equine herpesvirus and feline calicivirus lasted for 7 days, while the feline herpesvirus lasted for 5 days. The eyewash did not lessen the survival time of any virus as compared to controls.
  • In the fluorescein solution, both the equine herpesvirus and feline herpesvirus (which are enveloped viruses) were not recoverable after 1 hour of inoculation. On the other hand, the feline calicivirus (a non-enveloped virus) survived in the solution for 7 days.
  • In the proparacaine solution, the equine herpesvirus and feline herpesvirus also did not remain infectious past the 1-hour mark post inoculation. However, the feline calicivirus could be recovered up to 24 hours post-inoculation.

Conclusions from the Study

  • The study suggests that these three viruses can be easily transmitted through the eyewash solution tested. Hence, there may be a risk of iatrogenic (caused by medical examination or treatment) transmission of these viruses through the use of these ophthalmic solutions.
  • The risk of such transmission was significantly reduced in both the fluorescein and proparacaine solutions. Notably, the feline calicivirus, the only non-enveloped virus in the study, remained viable longer in both these solutions.

Cite This Article

APA
Storey ES, Gerding PA, Scherba G, Schaeffer DJ. (2002). Survival of equine herpesvirus-4, feline herpesvirus-1, and feline calicivirus in multidose ophthalmic solutions. Vet Ophthalmol, 5(4), 263-267. https://doi.org/10.1046/j.1463-5224.2002.00234.x

Publication

ISSN: 1463-5216
NlmUniqueID: 100887377
Country: England
Language: English
Volume: 5
Issue: 4
Pages: 263-267

Researcher Affiliations

Storey, Eric S
  • Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois, Urbana 61802, USA. storeye@hotmail.com
Gerding, Paul A
    Scherba, Gail
      Schaeffer, David J

        MeSH Terms

        • Animals
        • Calicivirus, Feline / drug effects
        • Calicivirus, Feline / pathogenicity
        • Cats
        • Cell Line
        • Cell Survival
        • Drug Storage
        • Fluorescein / pharmacology
        • Herpesviridae / drug effects
        • Herpesviridae / pathogenicity
        • Herpesvirus 4, Equid / drug effects
        • Herpesvirus 4, Equid / pathogenicity
        • Horses
        • Ophthalmic Solutions / pharmacology
        • Propoxycaine / pharmacology
        • Temperature
        • Viruses / drug effects
        • Viruses / pathogenicity

        Citations

        This article has been cited 3 times.
        1. Lamontagne J, Mills C, Mao R, Goddard C, Cai D, Guo H, Cuconati A, Block T, Lu X. Screening and identification of compounds with antiviral activity against hepatitis B virus using a safe compound library and novel real-time immune-absorbance PCR-based high throughput system. Antiviral Res 2013 Apr;98(1):19-26.
        2. Thiry E, Addie D, Belák S, Boucraut-Baralon C, Egberink H, Frymus T, Gruffydd-Jones T, Hartmann K, Hosie MJ, Lloret A, Lutz H, Marsilio F, Pennisi MG, Radford AD, Truyen U, Horzinek MC. Feline herpesvirus infection. ABCD guidelines on prevention and management. J Feline Med Surg 2009 Jul;11(7):547-55.
          doi: 10.1016/j.jfms.2009.05.003pubmed: 19481034google scholar: lookup
        3. Gould D. Feline herpesvirus-1: ocular manifestations, diagnosis and treatment options. J Feline Med Surg 2011 May;13(5):333-46.
          doi: 10.1016/j.jfms.2011.03.010pubmed: 21515221google scholar: lookup